DENTSPLY SIRONA Director Jonathan Mazelsky Receives 22,822 Restricted Stock Units

This SEC Form 4 filing reports that Jonathan Jay Mazelsky, a director of DENTSPLY SIRONA Inc. (XRAY), received 22,822 restricted stock units (RSUs) on June 3, 2026. The RSUs were granted at $0 per share and consist entirely of restricted stock units that vest in full one year from the date of grant. Following this transaction, Mazelsky's total holdings in DENTSPLY SIRONA common stock increased to 51,668.534 shares. The filing was signed by Jessica Nielsen Causey as attorney-in-fact for Mazelsky on June 5, 2026. This represents a standard equity compensation award to a company director, with the RSUs serving as long-term incentive compensation that aligns the director's interests with those of shareholders through vesting requirements.